PMC:7787218 / 17628-18237 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"302","span":{"begin":33,"end":38},"obj":"Gene"}],"attributes":[{"id":"A302","pred":"tao:has_database_id","subj":"302","obj":"Gene:43740568"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"RNA-based vaccine mRNA encoding spike protein (30 μg) BioNTech–Pfizer(BNT162b2) Two doses (day 0, day 21)\nIntramuscular Post-EUA 0.43 mg ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 0.05 mg2[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 0.09 mg 1,2-distearoyl-sn-glycero-3-phosphocholine, and 0.2 mg cholesterol, 0.01 mg potassium chloride, 0.01 mg monobasic potassium phosphate, 0.36 mg sodium chloride, 0.07 mg dibasic sodium phosphate dihydrate, and 6 mg sucrose. The diluent (0.9% sodium chloride Injection) contributes an additional 2.16 mg sodium chloride per dose"}

{"project":"LitCovid-sentences","denotations":[{"id":"T76","span":{"begin":0,"end":108},"obj":"Sentence"},{"id":"T77","span":{"begin":109,"end":505},"obj":"Sentence"},{"id":"T78","span":{"begin":506,"end":609},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"RNA-based vaccine mRNA encoding spike protein (30 μg) BioNTech–Pfizer(BNT162b2) Two doses (day 0, day 21)\nIntramuscular Post-EUA 0.43 mg ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 0.05 mg2[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 0.09 mg 1,2-distearoyl-sn-glycero-3-phosphocholine, and 0.2 mg cholesterol, 0.01 mg potassium chloride, 0.01 mg monobasic potassium phosphate, 0.36 mg sodium chloride, 0.07 mg dibasic sodium phosphate dihydrate, and 6 mg sucrose. The diluent (0.9% sodium chloride Injection) contributes an additional 2.16 mg sodium chloride per dose"}